These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Apoptotic and proliferative activity in the neoplastic progression of Barrett's oesophagus: a comparative study. Whittles CE; Biddlestone LR; Burton A; Barr H; Jankowski JA; Warner PJ; Shepherd NA J Pathol; 1999 Apr; 187(5):535-40. PubMed ID: 10398118 [TBL] [Abstract][Full Text] [Related]
27. Activation of Akt is increased in the dysplasia-carcinoma sequence in Barrett's oesophagus and contributes to increased proliferation and inhibition of apoptosis: a histopathological and functional study. Beales IL; Ogunwobi O; Cameron E; El-Amin K; Mutungi G; Wilkinson M BMC Cancer; 2007 Jun; 7():97. PubMed ID: 17559672 [TBL] [Abstract][Full Text] [Related]
28. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort. Dulai GS; Shekelle PG; Jensen DM; Spiegel BM; Chen J; Oh D; Kahn KL Am J Gastroenterol; 2005 Apr; 100(4):775-83. PubMed ID: 15784018 [TBL] [Abstract][Full Text] [Related]
29. Barrett's oesophagus: intestinal metaplasia is not essential for cancer risk. Kelty CJ; Gough MD; Van Wyk Q; Stephenson TJ; Ackroyd R Scand J Gastroenterol; 2007 Nov; 42(11):1271-4. PubMed ID: 17852872 [TBL] [Abstract][Full Text] [Related]
30. Dedifferentiation precedes invasion in the progression from Barrett's metaplasia to esophageal adenocarcinoma. Helm J; Enkemann SA; Coppola D; Barthel JS; Kelley ST; Yeatman TJ Clin Cancer Res; 2005 Apr; 11(7):2478-85. PubMed ID: 15814623 [TBL] [Abstract][Full Text] [Related]
31. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754 [TBL] [Abstract][Full Text] [Related]
33. Esophageal polypoid dysplasia of gastric foveolar phenotype with focal intramucosal carcinoma associated with Barrett's esophagus. Asthana N; Mandich D; Ligato S Am J Surg Pathol; 2008 Oct; 32(10):1581-5. PubMed ID: 18724240 [TBL] [Abstract][Full Text] [Related]
34. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus. Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552 [TBL] [Abstract][Full Text] [Related]
36. Detection of genetic changes in Barrett's adenocarcinoma and Barrett's esophagus by DNA in situ hybridization and immunohistochemistry. Krishnadath KK; Tilanus HW; Alers JC; Mulder AH; van Dekken H Cytometry; 1994 Feb; 15(2):176-84. PubMed ID: 8168405 [TBL] [Abstract][Full Text] [Related]
37. The expression of 8-hydroxydeoxyguanosine in oesophageal tissues and tumours. Räsänen JV; Sihvo EI; Ahotupa MO; Färkkilä MA; Salo JA Eur J Surg Oncol; 2007 Dec; 33(10):1164-8. PubMed ID: 17467227 [TBL] [Abstract][Full Text] [Related]
38. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation. Kimchi ET; Posner MC; Park JO; Darga TE; Kocherginsky M; Karrison T; Hart J; Smith KD; Mezhir JJ; Weichselbaum RR; Khodarev NN Cancer Res; 2005 Apr; 65(8):3146-54. PubMed ID: 15833844 [TBL] [Abstract][Full Text] [Related]